Company Overview of AutoGenomics, Inc.
AutoGenomics, Inc., a molecular diagnostics company, provides automated microarray technology solutions for molecular diagnostics. It develops an automated, microarray based multiplexing diagnostic platform for assessing disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer, and pharmacogenetics. The company also provides INFINITI System, a multiplexing, continuous flow, random access microarray platform that offers high performance genetic marker detection with varying options in automation and throughput; and INFINITI PLUS Analyzer, an automated, multiplexing, continuous flow, and random access microarray instrument that in...
2980 Scott Street
Vista, CA 92081
Founded in 1999
Key Executives for AutoGenomics, Inc.
Founder, Chairman, Chief Executive Officer, President and Member of Nominating & Corporate Governance Committee
Co-Founder and Senior Vice President of Lab Services
Co-Founder and Vice President of System Development
Chief Financial Officer and Secretary
Compensation as of Fiscal Year 2015.
AutoGenomics, Inc. Key Developments
AutoGenomics, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 09:00 AM
Jun 18 15
AutoGenomics, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 09:00 AM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Fareed Kureshy, Founder, Chairman, Chief Executive Officer, President and Member of Nominating & Corporate Governance Committee.
AutoGenomics, Inc. and Genomas Announce Strategic Partnership for the Development of DNA-Guided Diagnostic Systems for the Treatment of Cardiovascular Disease, Obesity and Diabetes
Jul 7 14
AutoGenomics, Inc. and Genomas announced that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes. This pioneering collaboration will provide clinicians and physicians with newly developed genetic tests and a decision support system which will allow them to manage statins, prescribe and dose these drugs on a DNA-guided, personalized basis to more effectively guide the therapy for each patient.
AutoGenomics, Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 04:00 PM
Feb 20 14
AutoGenomics, Inc. Presents at 26th Annual ROTH Conference, Mar-11-2014 04:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|